Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heiwa Clinic is a specialized medical institution located in Yokohama, Japan, and serves as a primary facility within the Zenjinkai Group, one of the country's largest dialysis networks. The clinic focuses on nephrology and renal replacement therapy, providing high-quality hemodialysis and peritoneal dialysis services to patients with chronic kidney disease. Beyond its clinical operations, Heiwa Clinic is a significant contributor to the global pharmaceutical industry as a high-volume clinical trial site for Phase 2 and Phase 3 studies. It has participated in numerous pivotal trials for renal and cardiovascular therapies, collaborating with major international and domestic pharmaceutical companies. The facility is equipped with advanced medical infrastructure and a multidisciplinary team of specialists dedicated to improving long-term outcomes for patients with renal failure. Its strategic location and large patient base make it a key partner for drug development in the Japanese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heiwa Clinic.